GlassScriptPhysician profile
Lindsay E Adams
NPI 1750628004
$2,932.09
in general payments reported to CMS, 2019-2025
13 companies · $537 in 2025
The $537 reported for 2025 was more than what 81% of Surgical providers received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $34.02 · 2022: $200 · 2023: $224 · 2024: $1,936 · 2025: $537.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,659 · Travel and Lodging: $1,039.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,659.45 |
| Travel and Lodging | $1,038.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $1,931.65 | 2022-2025 | Inspire |
| Genzyme Corporation | $346.22 | 2022-2025 | |
| Regeneron Healthcare Solutions, INC. | $326.63 | 2023-2025 | Dupixent |
| Boston Scientific Corporation | $61.60 | 2024-2025 | Wavewriter Alpha Prime 16, Infinion 16 |
| Revance Therapeutics, INC. | $60.43 | 2025 | Daxxify |
| Abbott Laboratories | $37.66 | 2025 | Amplatzer Piccolo |
| Aerin Medical INC. | $35.39 | 2022 | |
| Genentech USA, INC. | $34.02 | 2021 | |
| Itamar Medical INC | $25.12 | 2023 | Watchpatone |
| Medtronic, INC. | $22.75 | 2023 | Stealthstation S8 Platform |
| Amgen INC. | $18.87 | 2024 | Tavneos |
| Kaleo, INC. | $16.15 | 2024 | Auvi-Q |
| Glaxosmithkline, LLC. | $15.60 | 2024 | Nucala |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lindsay Adams listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.